Adverum Biotechnologies Files Initial Beneficial Ownership Statement for Frazier Life Sciences Public Fund
Adverum Biotechnologies Inc. has filed an initial statement of beneficial ownership with the SEC, naming Frazier Life Sciences Public Fund, L.P. as the beneficial owner. This filing was made on December 05, 2025, and is accessible via the SEC's EDGAR system.
Adverum Biotechnologies Inc. has filed an initial statement of beneficial ownership with the Securities and Exchange Commission, naming Frazier Life Sciences Public Fund, L.P. as the beneficial owner. The full filing can be accessed through the link below. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Adverum Biotechnologies Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001231919-25-000577), on December 05, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT) Original Document: here
